SCHEMBL4429778

SCHEMBL4429778

COCCOc1ccc(-c2c(C#N)c(N)nc(SCc3ccccn3)c2C#N)cc1

nearest known ligand 0.62

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 18/20 0.62
ALDH1A1 P00352 2/20 0.60
PKM P14618 1/20 0.60
SMN1; SMN2 Q16637 1/20 0.60
ADORA3 P0DMS8 3/20 0.59
ADORA2A P29274 3/20 0.59
ADORA2B P29275 3/20 0.56
SLC6A3 Q01959 1/20 0.55
KDM4E B2RXH2 1/20 0.55
MEN1 O00255 1/20 0.55
USP2 O75604 1/20 0.55
TP53 P04637 1/20 0.55
MAPT P10636 1/20 0.55
HPGD P15428 1/20 0.55
ALOX15 P16050 1/20 0.55
KMT2A Q03164 1/20 0.55
HSD17B10 Q99714 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31409453 1.00 ADORA1 (0.62) ADORA1ALDH1A1PKMSMN1; SMN2ADORA3
SCHEMBL31370980 0.90 ALDH1A1 (0.59) ADORA1ALDH1A1PKMSMN1; SMN2ADORA3
SCHEMBL13929510 0.90 ALDH1A1 (0.61) ADORA1ALDH1A1PKMSMN1; SMN2ADORA3
SCHEMBL26012324 0.88 ALDH1A1 (0.57) ADORA1ALDH1A1PKMSMN1; SMN2ADORA3
SCHEMBL26013193 0.88 ADORA1 (0.58) ADORA1ALDH1A1SMN1; SMN2ADORA3ADORA2A
SCHEMBL4428648 0.86 ADORA1 (0.85) ADORA1ALDH1A1PKMSMN1; SMN2SLC6A3
SCHEMBL26014395 0.86 ADORA1 (0.55) ADORA1ALDH1A1SMN1; SMN2ADORA3ADORA2A
SCHEMBL26010525 0.85 KDM4E (0.64) ADORA1ALDH1A1SMN1; SMN2ADORA3ADORA2A
SCHEMBL13929771 0.84 ADORA1 (0.62) ADORA1ALDH1A1PKMSMN1; SMN2SLC6A3
SCHEMBL4427010 0.84 ADORA1 (0.74) ADORA1ALDH1A1ADORA3ADORA2AADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1455785-B1 SUBSTITUTED 2-THIO-3,5-DICYANO-4-PHENYL-6-AMINOPYRIDINES AND THE USE OF THE SAME BAYER HEALTHCARE AG (DE) 2009-03-04 EP disclosed
WO-2007073855-A1 USE OF ADENOSINE A1 RECEPTOR AGONISTS FOR THE PROTECTION OF RENAL CELLS AGAINST TOXIC EFFECTS CAUSED BY AMINOGLYCOSIDES DURING TREATMENT OF INFECTIOUS DISEASES BAYER HEALTHCARE AG (DE) 2007-07-05 WO disclosed
US-20060217373-A1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same BAYER HEALTHCARE AG (DE) 2006-09-28 US disclosed
US-7109218-B2 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same BAYER HEALTHCARE AG (DE) 2006-09-19 US disclosed
US-20050227972-A1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same BAYER HEALTHCARE AG (DE) 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050227972-A1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same TPMT, QDPR, TUBB6 ADORA1 998/4885ALDH1A1 686/4885PKM 740/4885
US-20060217373-A1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same TPMT, QDPR, TUBB6 ADORA1 998/4885ALDH1A1 686/4885PKM 740/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.